Asahi Glass Acquires German Bio Contract Manufacturer Biomeva Sep. 14, 2016 Filed Under: Industry, Pharma Tagged With: Asahi Glass, Biomeva, biopharmaceuticals, iPS cellsAsahi Glass Co. Ltd. (TYO:5201) has acquired all the shares of Biomeva GmbH, a biopharmaceutical contract manufacturing organization (CMO) based…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Asahi Kasei Medical to Enter Pharmaceutical CDMO BusinessAGC in Race to Bolster CDMO Operations Across US, Europe and…Chitose Bio Evolution Moves Forward on Chemical, Bio-CDMO…JSR Pursues New Developments in Life Sciences BusinessTaiwan Looks to Establish CDMOs for mRNA TechnologyAsahi Kasei Targets Sales of 1 Trillion Yen in Health Care…